Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and alloxan

pyrrolidine dithiocarbamate has been researched along with alloxan in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ângelo, ML; Ceron, CS; Costa, KCM; de Araújo Paula, FB; do Valle, GT; Novaes, RD; Pereira, BP; Ruginsk, SG; Salles, BCC; Tirapelli, CR; Torres, LHL	1

Other Studies

1 other study(ies) available for pyrrolidine dithiocarbamate and alloxan

Article	Year
Pyrrolidine dithiocarbamate reduces alloxan-induced kidney damage by decreasing nox4, inducible nitric oxide synthase, and metalloproteinase-2. Naunyn-Schmiedeberg's archives of pharmacology, 2020, Volume: 393, Issue:10 Topics: Alloxan; Animals; Antioxidants; Kidney Diseases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; NADPH Oxidase 4; Nitric Oxide Synthase Type II; Pyrrolidines; Rats; Rats, Wistar; Thiocarbamates	2020

Article

Year

Pyrrolidine dithiocarbamate reduces alloxan-induced kidney damage by decreasing nox4, inducible nitric oxide synthase, and metalloproteinase-2.

Naunyn-Schmiedeberg's archives of pharmacology, 2020, Volume: 393, Issue:10

Topics: Alloxan; Animals; Antioxidants; Kidney Diseases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; NADPH Oxidase 4; Nitric Oxide Synthase Type II; Pyrrolidines; Rats; Rats, Wistar; Thiocarbamates

2020